why choose us

First received: February 22, 2023

Clinical Trial: MYLUNG Consortium Part 3: Observational Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Carcinoma, Non-Small-Cell Lung

Study Type: OBSERVATIONAL


Official Title: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Longitudinal Prospective RWE Study (MYLUNG Consortium Part 3: Observational Study)

Brief Summary: This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.

Read more